Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
The retroviral accessory proteins S2, Nef, and glycoMA use similar mechanisms for antagonizing the host restriction factor SERINC5.
Ahmad I
,
Li S
,
Li R
,
Chai Q
,
Zhang L
,
Wang B
,
Yu C
,
Zheng YH
.
Abstract
Serine incorporator 5 (SERINC5) is a recently identified restriction factor that blocks virus entry but is antagonized by three unrelated retroviral accessory proteins. The S2 protein from equine infectious anemia virus (EIAV) has been reported to reduce SERINC5 expression at steady-state levels likely via the endocytic pathway; however, the precise mechanism is still unclear. Here, we investigated how EIAV S2 protein down-regulates SERINC5 compared with down-regulation induced by Nef from HIV-1 and glycoMA proteins from murine leukemia virus (MLV). Using bimolecular fluorescence complementation (BiFC) assay and immunoprecipitation (IP), we detected an interaction between S2 and SERINC5. We found that this interaction relies on the S2 myristoylation site, indicating that it may occur on the plasma membrane. S2 internalized SERINC5 via receptor-mediated endocytosis and targeted it to endosomes and lysosomes, resulting in a ubiquitination-dependent decrease in SERINC5 expression at steady-state levels. Both BiFC and IP detected a glycoMA-SERINC5 interaction, but a Nef-SERINC5 interaction was detected only by BiFC. Moreover, S2 and glycoMA down-regulated SERINC5 more effectively than did Nef. We further show that unlike Nef, both S2 and glycoMA effectively down-regulate SERINC2 and also SERINC5 from Xenopus tropicalis (xSERINC5). Moreover, we detected expression of the equine SERINC5 (eSERINC5) protein and observed that its expression is much weaker than expression levels of SERINC5 from other species. Nonetheless, eSERINC5 had a strong antiviral activity that was effectively counteracted by S2. We conclude that HIV-1, EIAV, and MLV share a similar mechanism to antagonize viral restriction by host SERINC5.
Ahi,
Functional Interplay Between Murine Leukemia Virus Glycogag, Serinc5, and Surface Glycoprotein Governs Virus Entry, with Opposite Effects on Gammaretroviral and Ebolavirus Glycoproteins.
2017, Pubmed
Ahi,
Functional Interplay Between Murine Leukemia Virus Glycogag, Serinc5, and Surface Glycoprotein Governs Virus Entry, with Opposite Effects on Gammaretroviral and Ebolavirus Glycoproteins.
2017,
Pubmed
Alvarado,
Interaction with the Src homology (SH3-SH2) region of the Src-family kinase Hck structures the HIV-1 Nef dimer for kinase activation and effector recruitment.
2015,
Pubmed
Bentham,
Role of myristoylation and N-terminal basic residues in membrane association of the human immunodeficiency virus type 1 Nef protein.
2006,
Pubmed
Chande,
S2 from equine infectious anemia virus is an infectivity factor which counteracts the retroviral inhibitors SERINC5 and SERINC3.
2018,
Pubmed
Cook,
Equine infectious anemia and equine infectious anemia virus in 2013: a review.
2014,
Pubmed
Craig,
Interaction of HIV-1 Nef with the cellular dileucine-based sorting pathway is required for CD4 down-regulation and optimal viral infectivity.
1998,
Pubmed
Dai,
A Long Cytoplasmic Loop Governs the Sensitivity of the Anti-viral Host Protein SERINC5 to HIV-1 Nef.
2019,
Pubmed
Deacon,
Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients.
1995,
Pubmed
Fagerness,
The S2 accessory gene of equine infectious anemia virus is essential for expression of disease in ponies.
2006,
Pubmed
Greenberg,
A dileucine motif in HIV-1 Nef is essential for sorting into clathrin-coated pits and for downregulation of CD4.
1999,
Pubmed
Inuzuka,
Serinc, an activity-regulated protein family, incorporates serine into membrane lipid synthesis.
2005,
Pubmed
Kestler,
Importance of the nef gene for maintenance of high virus loads and for development of AIDS.
1991,
Pubmed
Kirchhoff,
Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection.
1995,
Pubmed
Li,
Murine Leukemia Virus Glycosylated Gag Reduces Murine SERINC5 Protein Expression at Steady-State Levels via the Endosome/Lysosome Pathway to Counteract SERINC5 Antiretroviral Activity.
2019,
Pubmed
Li,
The S2 gene of equine infectious anemia virus is a highly conserved determinant of viral replication and virulence properties in experimentally infected ponies.
2000,
Pubmed
Li,
A live attenuated equine infectious anemia virus proviral vaccine with a modified S2 gene provides protection from detectable infection by intravenous virulent virus challenge of experimentally inoculated horses.
2003,
Pubmed
Park,
Adaptor protein complexes and intracellular transport.
2015,
Pubmed
Payne,
Characterization of infectious molecular clones of equine infectious anaemia virus.
1994,
Pubmed
Rosa,
HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation.
2016,
Pubmed
Saksela,
Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4.
1995,
Pubmed
Shi,
HIV-1 Nef Antagonizes SERINC5 Restriction by Downregulation of SERINC5 via the Endosome/Lysosome System.
2018,
Pubmed
Sood,
SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins.
2017,
Pubmed
Trautz,
The Antagonism of HIV-1 Nef to SERINC5 Particle Infectivity Restriction Involves the Counteraction of Virion-Associated Pools of the Restriction Factor.
2017,
Pubmed
Usami,
SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef.
2016,
Pubmed
Zhang,
Identification of SERINC5-001 as the Predominant Spliced Isoform for HIV-1 Restriction.
2017,
Pubmed
Zheng,
Mutations occurring during serial passage of Japanese equine infectious anemia virus in primary horse macrophages.
2000,
Pubmed
Zheng,
In vivo dynamics of equine infectious anemia viruses emerging during febrile episodes: insertions/duplications at the principal neutralizing domain.
1997,
Pubmed
Zheng,
Insertions, duplications and substitutions in restricted gp90 regions of equine infectious anaemia virus during febrile episodes in an experimentally infected horse.
1997,
Pubmed
de Sousa-Pereira,
The antiviral activity of rodent and lagomorph SERINC3 and SERINC5 is counteracted by known viral antagonists.
2019,
Pubmed
